WHO

Mounting scientific evidence is reinforcing the role of regular physical activity in reducing cancer risk and improving outcomes among survivors. Health authorities are increasingly integrating exercise into national cancer control strategies, citing its measurable impact on lowering incidence rates of several major malignancies. Beyond prevention, structured movement programs are demonstrating benefits in treatment tolerance, recurrence reduction and quality-of-life improvement.

World Health Organization has intensified its global polio vaccination efforts, warning that hard-won gains against the disease remain vulnerable without sustained immunization coverage. Health officials emphasize that uneven vaccination, conflict-driven disruptions, and misinformation continue to pose risks in several regions. The renewed push focuses on strengthening routine immunization, deploying targeted campaigns, and supporting national health systems to prevent resurgence.

The World Health Organization (WHO) has released new guidance regarding the use of GLP-1 receptor agonists, a class of medications increasingly prescribed for obesity management. Recognized for their effectiveness in promoting weight loss and improving metabolic health, these drugs are now recommended with specific precautions to ensure safe and equitable usage, particularly in populations with limited access.

The World Health Organization (WHO) has raised alarms over persistent gaps in measles vaccination coverage worldwide, warning that millions of children remain vulnerable to this highly contagious disease. Despite the availability of safe and effective vaccines, global immunization rates have stagnated, fueled by logistical challenges, misinformation, and health inequities. WHO emphasizes the urgent need to strengthen routine immunization programs, conduct catch-up campaigns, and increase public awareness.

The World Health Organization (WHO) has released updated guidelines for tuberculosis (TB) management, reflecting advances in diagnostics, treatment protocols, and strategies to address drug-resistant strains. The revisions emphasize early detection, shorter treatment regimens, and integrated care models to reduce transmission and improve patient outcomes. Rising rates of multidrug-resistant TB (MDR-TB) and extensive drug-resistant TB (XDR-TB) pose significant health and economic risks, with potential costs exceeding Rs.

The World Health Organization (WHO) has issued a stark warning about the accelerating rise of antibiotic resistance worldwide, highlighting a growing threat to public health and global economies. Increasing misuse of antibiotics in healthcare, agriculture, and livestock is driving the evolution of multidrug-resistant pathogens, reducing the effectiveness of essential treatments. WHO reports indicate that infections once easily treatable are now becoming life-threatening, with a potential annual economic burden in the trillions of Rs.

The World Health Organization (WHO) has issued a caution regarding three Indian-manufactured cough syrups, citing safety risks linked to child fatalities. The warning underscores concerns over potential toxic ingredients and improper manufacturing standards. Authorities are urged to halt the use and distribution of the identified products while conducting rigorous investigations. The advisory serves as a stark reminder of the critical importance of stringent pharmaceutical oversight, particularly in pediatric medications.

India has recorded a significant 43% reduction in the number of zero-dose children—those who have not received a single vaccine—according to the latest joint assessment by the World Health Organization and UNICEF. This notable progress reflects an enhanced national commitment to universal immunization and targeted outreach in underserved communities. The development signals India's improving healthcare infrastructure, even as global immunization rates recover unevenly from pandemic-era disruptions.

At the International AIDS Conference held in Kigali, Rwanda, World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus delivered a poignant call for renewed global solidarity and sustained investment in the fight against AIDS. While acknowledging the notable progress made in curbing new infections and expanding access to treatment, Dr. Tedros emphasized that the mission remains far from over. He warned that disparities in care, funding gaps, and emerging health crises threaten to derail decades of advancement.

The World Health Organization (WHO) has released its first-ever position paper on immunization strategies against Respiratory Syncytial Virus (RSV), a leading cause of infant mortality. The paper introduces two key immunization approaches: a maternal vaccine designed to transfer antibodies to unborn infants, and a long-acting monoclonal antibody offering protection to infants for up to five months. The recommendations aim to reduce RSV-related deaths, particularly in low- and middle-income countries, where the virus has its most severe impact.